Predict your next investment

Venture Capital
tichenorventures.com

See what CB Insights has to offer

Investments

8

Portfolio Exits

3

About Tichenor Ventures

Tichenor Ventures Headquarter Location

100 Crescent Court Suite 700

Dallas, Texas, 75201,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Tichenor Ventures News

OS Therapies lands $6M series A to support osteosarcoma program, drug conjugate platform

Apr 21, 2021

April 20, 2021 OS Therapies LLC, the developer of a listeria-based cancer vaccine to prevent metastasis and increase overall survival in young people with osteosarcoma, has closed on a $6 million series A financing led by Noble Capital Markets and Tichenor Ventures. The funds will help the company advance its lead candidate, OST-HER2, into a phase IIb trial this year with hopes of a potential FDA filing by in 2022.

Tichenor Ventures Investments

8 Investments

Tichenor Ventures has made 8 investments. Their latest investment was in OS Therapies as part of their Series A on April 4, 2021.

CBI Logo

Tichenor Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/21/2021

Series A

OS Therapies

$6M

Yes

Noble Capital Markets, and Undisclosed Investors

2

2/20/2019

Series E

Subscribe to see more

$99M

Subscribe to see more

10

9/15/2016

Series D

Subscribe to see more

$99M

Subscribe to see more

10

3/23/2015

Series D

Subscribe to see more

$99M

Subscribe to see more

10

5/3/2013

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/21/2021

2/20/2019

9/15/2016

3/23/2015

5/3/2013

Round

Series A

Series E

Series D

Series D

Series C

Company

OS Therapies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$6M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Noble Capital Markets, and Undisclosed Investors

Sources

2

10

10

10

10

Tichenor Ventures Portfolio Exits

3 Portfolio Exits

Tichenor Ventures has 3 portfolio exits. Their latest portfolio exit was Peloton Therapeutics on May 21, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/21/2019

Acquired

$99M

3

4/4/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

11/2/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/21/2019

4/4/2019

11/2/2016

Exit

Acquired

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.